Intellectual Property

Intellectual property disputes take place on a daily basis in a variety of venues. From an employee’s right to a patent of company-developed products to patent wars between international companies for illegal use of a product/logo, the National Law Review is a great resource for updates on all things IP. The site covers litigation at the United States Patent and Trademark Office (USPTO) and the  Patent Trial and Board Appeals (PTAB), as well as cases in front of the International Trade Commission (ITC) for international patent disputes. The National Law Review covers cases heard by the Supreme Court of the United States (SCOTUS), or appeals which are now sitting in front of the patent-board on Inter partes review (IPR). Additionally, the National Law Review covers cases and decisions of the Federal Trade Commission (FTC).

Copyrights, patent infringement claims, trade secrets, false advertising claims, unfair competition, and intellectual property laws which govern patent-litigation, are all areas which the National Law Review covers, in detail for readers. Patent disputes don’t only occur in the United States. When international countries including the United Kingdom, Brazil, China, India, and the European Union get involved, international laws are also taken into consideration by the PTO. Additionally, information on how to obtain patent protection internationally is also available on the National Law Review.

Intellectual property news on the National Law Review spans from topics including biosimilars, domain name registration, generic top-level domains (gTLDs), drug patents, non-compete agreements, trade secrets, and other industry-related battles which ensue, are covered on the site. Visitors can read about the latest legislation, laws, and news, as it relates to patents and intellectual property in general. Further, visitors to the National Law Review are going to find the latest stories and litigation as it unfolds in front of patent courts across the land. From email and data retention policies, patent disputes over medical devices, cloud computing and artificial intelligence the National Law Review has the details and expert intellectual property litigation legal analysis readers count on.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort descending
Sep
24
2020
China Issues Draft Provisions on the Protection of Geographical Indications Schwegman, Lundberg & Woessner, P.A.
Oct
29
2020
Contents of the Chinese Patent Bar Exam Schwegman, Lundberg & Woessner, P.A.
Nov
6
2020
Chinese Patent Bar Exam Postponed in Western China Due to COVID-19 Outbreak Schwegman, Lundberg & Woessner, P.A.
Sep
11
2014
FDA Publishes “Purple Book” for Biologicals/Biosimilars Schwegman, Lundberg & Woessner, P.A.
Feb
6
2017
Are Patent-Friendly PTAB Decisions On the Rise? Schwegman, Lundberg & Woessner, P.A.
Dec
15
2020
China Releases Amended Patent Examination Guidelines Focusing on Pharma and Biotech Schwegman, Lundberg & Woessner, P.A.
Dec
18
2020
Chinese Patent Application Filings Jump Almost 33% in November 2020 Month-on-Month Schwegman, Lundberg & Woessner, P.A.
Sep
30
2014
American Calcar v. Amer. Honda Motor Co. – Therasense Goes Out For a Test Drive Schwegman, Lundberg & Woessner, P.A.
Jan
13
2021
USPTO Releases Report on Distortions Caused by Chinese Monetary Incentives for U.S. Filings Schwegman, Lundberg & Woessner, P.A.
Apr
6
2021
China Releases Interpretation of the Measures Regarding the Regulation of Patent Applications That May Prevent Some IP Holding Companies from Successfully Prosecuting Patent Applications Schwegman, Lundberg & Woessner, P.A.
May
27
2017
Supreme Court Interprets Patent Venue Statute in Unanimous Opinion Schwegman, Lundberg & Woessner, P.A.
Apr
14
2021
Guest Post: Well-Known Mark Recognitions in China – Part I Schwegman, Lundberg & Woessner, P.A.
Apr
19
2021
Chinese Patent Grants Up 77% in First Quarter of 2021 Schwegman, Lundberg & Woessner, P.A.
May
2
2021
China’s National People’s Congress Releases English Translation of Civil Code Including Intellectual Property Law Articles Schwegman, Lundberg & Woessner, P.A.
Jun
14
2017
Exhausted by Exhaustion: Impression Products v. Lexmark Schwegman, Lundberg & Woessner, P.A.
May
12
2021
China to Further Crack Down on Malicious Trademark Applications and Irregular Patent Applications; Potentially Raise Filing Fees Schwegman, Lundberg & Woessner, P.A.
Dec
18
2014
Mayo Meet Alice Meet Myriad – Fed. Cir. Appreciates “Abstract Art” Schwegman, Lundberg & Woessner, P.A.
Jul
13
2017
Strong Intellectual Property Protection Encourages Innovation, according to Congressman Schwegman, Lundberg & Woessner, P.A.
Jul
7
2021
China’s Supreme People’s Court Releases Patent Linkage Trial Provisions Schwegman, Lundberg & Woessner, P.A.
Sep
4
2021
Belcher v. Hospira – Inequitable Conduct is Still in Your Invalidity Toolbox Schwegman, Lundberg & Woessner, P.A.
Apr
10
2011
Use Petitions to Reverse Determination of No SNQ (Substantial New Questions of Patentability) in Inter Partes Reexamination Schwegman, Lundberg & Woessner, P.A.
Jul
1
2011
Report From Bio International Convention in DC– Everyone In the Patent Pool! Schwegman, Lundberg & Woessner, P.A.
Jul
25
2011
Inequitable Conduct in Canada – Disarming the “Atomic Bomb” Schwegman, Lundberg & Woessner, P.A.
Aug
3
2011
Wegner Paper Probes Myriad Decisions Flaws Schwegman, Lundberg & Woessner, P.A.
Mar
31
2022
Intellectual Property in Russia Schwegman, Lundberg & Woessner, P.A.
Aug
31
2011
Obviousness Objections Based On Combinations Of References – Consistent Warnings From The CAFC Schwegman, Lundberg & Woessner, P.A.
Oct
11
2017
Amgen v. Sanofi – Invalidation Without Representation? Schwegman, Lundberg & Woessner, P.A.
Jun
3
2022
Beijing IP Court: Suing Others with A Trademark Not Obtained in Good Faith Constitutes an Abuse of Rights Schwegman, Lundberg & Woessner, P.A.
Jun
11
2022
China Claims Over 18,000 5G Standard Essential Patent Families Ranking First in the World Schwegman, Lundberg & Woessner, P.A.
Jun
29
2015
“If Wishes Were Horses” – Roberts’ Dissent from Myriad Schwegman, Lundberg & Woessner, P.A.
Dec
8
2017
Ex Parte Patterson: Assay Based on Two “Natural Phenomena” Does Not Equal One “Inventive Concept” Schwegman, Lundberg & Woessner, P.A.
Dec
25
2017
Aqua Products Sinks PTAB Decision in Bosch v. Matal Schwegman, Lundberg & Woessner, P.A.
Mar
20
2012
Supreme Court Reverses In Prometheus v. Mayo! Schwegman, Lundberg & Woessner, P.A.
Mar
26
2012
Patent and Trademark Office (PTO) To Biotech Examiners – We’ll Get Back To You! Schwegman, Lundberg & Woessner, P.A.
Apr
20
2012
Eurand v. Mylan –A “School Of Obviousness" Schwegman, Lundberg & Woessner, P.A.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins